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Background: Changes in diet and exercise have been separately demonstrated to improve Depression, although
scientific evidence available is scarce. In a previously published controlled study, just recommending these and
other lifestyle measures (sleep restriction and sunlight exposure) in combination once, patients experienced
improvements in their depressive symptoms six months later. In this sample, one in three depressive patients
had metabolic syndrome (MetS) at baseline. First line treatment of MetS condition is hygienic-dietetic, being
Mediterranean diet and exercise especially important. Therefore we analyzed if lifestyle recommendations also
improved their metabolic profile.
Findings: During the sixth month evaluation, a smaller number of patients from the group receiving
hygienic-dietary recommendations met MetS criteria comparing with the control group.
Conclusions: This study suggests that costless lifestyle recommendations, such as exercise and Mediterranean diet,
have the capacity to promote both mental and physical health in a significant proportion of depressive patients.
Further research is needed to confirm or discard these preliminary findings.
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Depression is a high prevalent disorder, prone to chron-
icity, and associated with a large burden in terms of suf-
fering, disability, and healthcare costs [1,2]. One of the
most common factors associated with depression is the
presence of somatic disorders [3]. Metabolic syndrome
(MetS) is a combination of risk factors (abdominal obes-
ity, hypertension, dyslipidemia, and glucose intolerance)
that are predictive of progression to coronary artery dis-
ease, type 2 diabetes, asthma and certain cancers [4,5].
MetS worsens with age and is rapidly growing in adults
and adolescents [6,7]. The prevalence of MetS in depres-
sion vary from 25 to 41% and depression increases the risk
of MetS from 1.7 to 2.8 times [8,9]. A complex bidirec-
tional interrelationship between depression and MetSyn* Correspondence: mauro.garcia@uib.es
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article, unless otherwise stated.has been suggested [8-10]. Patients with Depression and
other mental disorders may be especially predisposed to
MetS since it has been proved it is triggered by psycho-
pharmacologic drug-induced adverse effects, sedentary
lifestyle, poor dietary habits, increased substance abuse
and possible limited access to health care [11,12]. There
are other biological mechanisms underlying the asso-
ciation between metabolic syndrome and depression,
but are not clearly established [13]. Biological links that
include increased pro-inflammatory cytokines, stress-
induced hyperactivity of the hypothalamic pituitary axis
(HPA), changes in homeostasis between the sympathe-
tic and parasympathetic nervous systems and cerebral
small vessel and circulation disease have been proposed
[14,15,8,9]. Pathophysiology overlap of depression and
MetS could offers new possibilities for simultaneous pre-
vention and treatment. Modification of risk factors should
be considered a primary target [10].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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style change, including exercise and nutrition therapy,
such as Mediterranean diet [6,7,11,16]. A Mediterranean
dietary pattern has been defined as comprising at least
two of the following components: high monounsaturated/
saturated fat ratio, low to moderate red wine consump-
tion, high consumption of legumes, high consumption of
grains and cereals, high consumption of fruits and vegeta-
bles, low consumption of meat and meat products and in-
creased consumption of fish, and moderate consumption
of milk and dairy products [17]. Diet and exercise have
been suggested able to normalize immune and metabolic
dysregulation in persons with MetS [18]. Diet and exercise
interventions have been also demonstrated to improve
depression although the evidence is still scarce [10].
However, to our knowledge, no previous research was
specifically aimed to determine the impact of exercise
and diet recommendations on patients with Depression
and MetS.
We hypothesized that hygienic-dietary recommenda-
tions can change the metabolic profile of patients with
Depression and MetSyn sixth months later.
Methods
Eighty outpatients with a depressive episode were re-
cruited for a randomized clinical trial that was designed
to test the effectiveness of lifestyle recommendations in
Depression [19,20]. The inclusion criteria were male and
female patients over 18 years; experiencing a depressive
episode according to DSM-IV diagnostic criteria for
Major Depressive Disorder, Dysthymic Disorder or Bipo-
lar Disorder; receiving antidepressant treatment; patients
who have the ability to communicate in Spanish and give
informed written consent and women of childbearing
age practicing safe contraceptive methods. Exclusion cri-
teria were: any other severe disease that affects the CNS;
uncontrolled or potentially interfering medical condi-
tion; delusions or hallucinations at the time of the study;
significant risk of suicide and pregnancy or lactation.
Complete analytic parameters (basal and six month’s
data) were available for fifty-one of those patients who
finished the study. Reasons for non-completion included
patient decision, protocol violation or appearance of a
severe, uncontrolled, or potentially interfering medical
condition. The study protocol was approved by the local
ethical board (CEIC: Comité Ético y de Investigación
Clínica de las Islas Baleares), and was registered (Trial
registration: Current Controlled Trials ISRCTN59506583)
and published elsewhere [19].
After signed informed consents outpatients were ran-
domly assigned either to the active treatment or the
control group. Patients assigned to the active treatment
group received an envelope containing a sheet of paper
with the four hygienic-dietary recommendations underconsideration. Two of them suggested diet changes, based
on Mediterranean diet guidelines, and exercising daily:
1. Go to bed when sleepy and not before 11 p.m. Use
your bed and bedroom only for sleep and sex (do not
read, watch TV or lie on the bed during the day). If
you do not fall asleep after 15 or 20 minutes, get up
and start an activity until you feel sleepy enough to
go back to bed. Get up early, never later than 9 a.m.,
no matter how well you have slept the night before.
Do not lie down or take a nap during the day.
2. Walk at least 1 hour a day, at a good pace but
without becoming short of breath or being unable
to talk while walking. If you think you have a
medical problem which makes walking difficult or
uncomfortable consult your doctor. Use appropriate
footwear for walking and have a shower or a bath
afterwards.
3. Expose yourself to sunlight at least 2 hours per day,
taking precautions to avoid sunburn or sunstroke
(sunscreen, hat, etc.).
4. Try to eat a healthy and balanced diet. Eat at
regular hours without snacking between meals. Avoid
especially sweet or sugary drinks. Eat fish at least
three times per week, plus fruit, cereals, nuts and
vegetables daily.
The control group received an identical envelope, but
in this case the recommendation was to perform the pat-
tern of eating and exercise according to what they
thought might make them feel better:
1. Sleep the hours that you feel your body needs.
2. Adapt the pace of daily physical activity that meets
your needs.
3. If exposed to sunlight take precautions to avoid
sunburn or sunstroke (sunscreen, hat, etc.).
4. Try to eat a healthy and balanced diet.
The Mini International Neuropsychiatric Interview
(MINI), the Hamilton rating scale for depression (HAM-D)
17-item version, the 21-item Beck Depression Inventory,
and the Clinical Global Impression scale (CGI) were used.
After the sixth month intervention tests were again ad-
ministered by blind raters. During this time the patients
were taking antidepressants, and continued to be treated
by their GP or psychiatrist without any interference from
the research team. Analytical determinations, blood pres-
sure and weight were measured at baseline and after six
months. The “International Diabetes Federation” (IDF)
criteria were used to define MetS in the patients [21]:
They must have central obesity, defined as excessive waist
circumference, with sex and ethnic specific values (≥94 cm
for European men) or BMI > 30 kg/m2 plus two or more
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150 mg/dl or specific treatment for this lipid abnormal-
ity; reduced concentration of high density lipoprotein
(HDL): < 40 mg/dl in men and < 50 mg/dl in women or
specific treatment for this lipid abnormality; raised
blood pressure: systolic blood pressure ≥ 130 mmHg or
diastolic blood pressure ≥ 85 mmHg or treatment of previ-
ously diagnosed hypertension; raised fasting plasma glu-
cose concentration ≥ 100 mg/dl or previously diagnosed
type 2 diabetes.
We conducted a statistical analysis using Fisher’s exact
test for categorical variables and U Man-Whitney test
for continuous variables.
Findings
Main socio-demographic and clinical data are presented
in Table 1. The antidepressants prescribed were very si-
milar in both groups; most of the patients used dual and
selective serotonin reuptake inhibitors. Scales indicated
an improvement of depressive symptoms in the active
treatment group, but due to the insufficient sample not
all the items reached statistical significance. Adverse ef-
fects resulting from these recommendations did not ap-
pear. Concerning to the metabolic variables shown in
Table 1, most changes were in terms of improving the
metabolic profile in the active group versus control rec-
ommendations. There was a statistically significant change
between pre and post condition in the number of pa-
tients in both groups that met MetS criteria (X2 = 4.69,
p = 0.03).Table 1 Demographic and clinical results
Active n = 25 Control n = 26 P value
Female sex, Nº 20 17 0.24
Age y, Mean (SD) 47.6 (11.6) 50.6 (11.4) 0.36
Major Depression, N° 23 20 0.28
HAM-D increment - 8.80 (8.9) - 5.57 (4.9) 0.11
BDI increment - 8.64 (9.2) - 4.25 (6.3) 0.05
GCI increment - 1.72 (1.3) - 0.69 (1.0) 0.00
BMI increment - 0.11 (1.5) 0.29 (1.6) 0.46
SBP increment - 2.33 (15.7) - 2.04 (16.9) 0.95
DBP increment 1.5 (12.9) - 1.76 (15.0) 0.47
Serum glucose increment - 3.9 (20.7) - 0.6 (21.3) 0.58
Total Cholesterol increment - 3.92 (21.9) 3.76 (39.2) 0.39
LDL Cholesterol increment - 7.00 (19.5) 3.00 (33.14) 0.20
HDL Cholesterol increment 1.76 (8.3) - 0.15 (8.1) 0.40
Triglycerides increment 6.4 (41.9) 9.3(62.8) 0.84
Metabolic Syndrome pre, N° 7 9
Metabolic Syndrome post, N° 3 10 0.03
Hamilton 17-item scale (HAM-D), Beck Depression Inventory 21-item (BDI,
Global Clinical Impression scale (GCI), Body Mass Index (BMI), Systolic Blood
Pressure (SBP), Diastolic Blood Pressure (DBP).Discussion
The main finding of this study is that MetS was lower in
those patients receiving the active hygienic-dietary rec-
ommendations compared to the control group. Perhaps
due to lack of statistical power, our study has not found
differences among any of the variables included in MetS
definition. Nevertheless, it has been suggested that it is
more important the association of Depression with the
construct of MetS rather than with its components [10].
Seasonality of serum lipids and weight/body mass in-
dex may affect MetS prevalence raising their development
in the winter [22]. Changes of plasma volume linked to
seasonal variations in temperature and/or physical activity
could be responsible of this fact [22]. However, these find-
ings cannot explain our results, since patients were as-
sessed throughout the year and assigned randomly to both
groups.
Depressed people are more prone to eat highly pala-
table and caloric food, rich in cholesterol and carbohy-
drate and low in fish, vegetable and cereals. This diet
does not ensure an adequate intake of B vitamins, folic
acids, and essential fatty acids for vascular, inflammatory
and metabolic balance, and may induce MetS [10]. De-
pression, when in comorbidity with MetS, shows worse
course, more severe clinical picture and a higher ten-
dency to chronicity and suicidality besides lower social
functioning [10]. It has been proposed the concept of
“metabolic depression” to identify a chronic subtype of
depression more frequent in late-life, with metabolic ab-
normalities and a protracted course [10,21]. Our prelim-
inary data could indicate that this situation can be faced
better when combining antidepressant treatment with
dietary hygienic measures.
Our study has some weaknesses that need to be ac-
knowledged for proper interpretation. The main limita-
tions of this study are the small sample size and the short
follow-up period. However, the small sample size would
not explain our positive findings but makes the type I stat-
istical error more probable. Although the vast majority of
patients met criteria for Major Depression, we also had
patients with Dysthymic and Bipolar Disorder. Due to the
limited sample we could not carry out a separate analysis
of these patients to determine if they have the same be-
havior against lifestyle recommendations.
Depression has been associated with poor adherence
to diet and exercise regimens [14,18]. There is no meas-
ure of adherence in this study. This is a clear limitation
because low adherence to the study recommendations
cannot be ruled out and this reinforces the fact that these
findings may simply be chance. Nevertheless we demon-
strated in a pilot study with a small part of these patients
using actigraphs, that they did change their lifestyle habits,
at least in a short-term period [23]. It would have been in-
teresting to dispose of objective adherence measures from
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could not be put into practice due to logistical limitations.
The benefits of lifestyle changes for patients experien-
cing a depressive episode and Metabolic Syndrome could
be achieved by using a simple combination of hygienic-
dietary recommendations on a written piece of paper.
These benefits applied to metabolic profile are a key factor
for patients’ future cardiovascular health which also con-
stitutes a key factor for their Mental Health evolution
[1,24-26]. The improvement of the metabolic profile
found in this study would be an extra-motivation for pa-
tients in order to maintain these lifestyle changes in the
long-term [16].
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